Crossmark

Pharmacological evaluation of Lonafarnib in reversing neurobehavioral, neurochemical and metabolic deficit in mouse models of chronic unpredictable mild stress (CUMS)

Crossref DOI link: https://doi.org/10.1007/s11011-026-01836-6

Published Online: 2026-04-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Vivek Kumar https://orcid.org/0000-0003-1678-4180
Singh, Shareen https://orcid.org/0000-0002-4242-3584
Kaur, Amritpal https://orcid.org/0009-0007-0732-4592
Mujwar, Somdutt https://orcid.org/0000-0003-4037-5475
Banerjee, Souvik https://orcid.org/0009-0000-3705-1539
Subramaniyan, Vetriselvan https://orcid.org/0000-0002-9629-9494
Dua, Kamal https://orcid.org/0000-0002-7507-1159
Singh, Thakur Gurjeet https://orcid.org/0000-0003-2979-1590
License Information

Text and Data Mining valid from 2026-04-10

Version of Record valid from 2026-04-10
More Information

Article History

Received: 14 October 2025

Accepted: 21 March 2026

First Online: 10 April 2026

Declarations

:

: Not applicable.

: The paper is submitted with the consent of all listed authors.

: The authors declare no competing interests.